These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3104964)

  • 1. Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level.
    Pomerleau CS; Pomerleau OF; Majchrzak MJ
    Psychopharmacology (Berl); 1987; 91(3):391-3. PubMed ID: 3104964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mecamylamine acutely increases human intravenous nicotine self-administration.
    Rose JE; Behm FM; Westman EC; Bates JE
    Pharmacol Biochem Behav; 2003 Sep; 76(2):307-13. PubMed ID: 14592683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mecamylamine increases nicotine preference and attenuates nicotine discrimination.
    Rose JE; Sampson A; Levin ED; Henningfield JE
    Pharmacol Biochem Behav; 1989 Apr; 32(4):933-8. PubMed ID: 2798542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.
    Lundahl LH; Henningfield JE; Lukas SE
    Pharmacol Biochem Behav; 2000 Jul; 66(3):637-43. PubMed ID: 10899382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of central and peripheral nicotinic blockade on human nicotine discrimination.
    Perkins KA; Sanders M; Fonte C; Wilson AS; White W; Stiller R; McNamara D
    Psychopharmacology (Berl); 1999 Feb; 142(2):158-64. PubMed ID: 10102768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
    Liu X; Caggiula AR; Yee SK; Nobuta H; Sved AF; Pechnick RN; Poland RE
    Neuropsychopharmacology; 2007 Mar; 32(3):710-8. PubMed ID: 16794568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute nicotine and mecamylamine administration on somatostatin concentration and binding in the rat brain.
    Barrios V; Rodriguez-Sanchez MN; Colas B; Arilla E
    Eur J Pharmacol; 1990 Apr; 179(3):263-70. PubMed ID: 1973104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low nicotine content cigarettes on smoke intake.
    Rose J; Behm F
    Nicotine Tob Res; 2004 Apr; 6(2):309-19. PubMed ID: 15203805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mecamylamine on human cigarette smoking and subjective ratings.
    Nemeth-Coslett R; Henningfield JE; O'Keeffe MK; Griffiths RR
    Psychopharmacology (Berl); 1986; 88(4):420-5. PubMed ID: 3085131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task.
    Terry AV; Buccafusco JJ; Jackson WJ; Zagrodnik S; Evans-Martin FF; Decker MW
    Psychopharmacology (Berl); 1996 Jan; 123(2):172-81. PubMed ID: 8741940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecamylamine reduces some EEG effects of nicotine chewing gum in humans.
    Pickworth WB; Herning RI; Henningfield JE
    Pharmacol Biochem Behav; 1988 May; 30(1):149-53. PubMed ID: 3174738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oral self-administration model of nicotine preference in rats: effects of mecamylamine.
    Glick SD; Visker KE; Maisonneuve IM
    Psychopharmacology (Berl); 1996 Dec; 128(4):426-31. PubMed ID: 8986014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecamylamine does not precipitate withdrawal in cigarette smokers.
    Eissenberg T; Griffiths RR; Stitzer ML
    Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and carbon monoxide exposure from inhalation of cigarillo smoke.
    Koszowski B; Rosenberry ZR; Kanu A; Viray LC; Potts JL; Pickworth WB
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):7-14. PubMed ID: 26459155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
    Phillips JM; Ehrlichman RS; Siegel SJ
    Neuroscience; 2007 Feb; 144(4):1314-23. PubMed ID: 17184927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
    Rose JE; Behm FM; Westman EC; Levin ED; Stein RM; Ripka GV
    Clin Pharmacol Ther; 1994 Jul; 56(1):86-99. PubMed ID: 8033499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
    Cohen C; Bergis OE; Galli F; Lochead AW; Jegham S; Biton B; Leonardon J; Avenet P; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Voltz C; Gardes A; Caille D; Perrault G; George P; Soubrie P; Scatton B
    J Pharmacol Exp Ther; 2003 Jul; 306(1):407-20. PubMed ID: 12682217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecamylamine blocks the development of tolerance to nicotine in rats: implications for the mechanisms of tolerance.
    McCallum SE; Caggiula AR; Epstein LH; Saylor S; Ploskina T; Sved AF
    Psychopharmacology (Berl); 1999 Jan; 141(3):332-8. PubMed ID: 10027516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.